India to Turkey: Lapatinib Export Trade Route

The India to Turkey Lapatinib corridor is one of India's established pharmaceutical export routes, with 18 shipments documented worth a combined $37.2K USD. The route is dominated by MBA PHARMACEUTICALS PRIVATE LIMITED, which alone accounts for roughly 67% of all export value, reflecting the consolidated nature of India's lapatinib manufacturing sector.

Across 6 active suppliers, the average shipment value stands at $2.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with lapatinib's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 21 days port-to-port. The route has recorded an annual growth rate of 16.2%, placing it at rank #2 among India's top lapatinib export destinations globally.

On the import side, key buyers of Indian lapatinib in Turkey include THE MANAGER - EKINOKSECZA DEPOSU SAN TIC AS, TO THE ORDER OF INVOICE RAISED TO, IMPORT PARTY CODE 1051 and 9 others. THE MANAGER - EKINOKSECZA DEPOSU SAN TIC AS is the single largest importer with 2 shipments valued at $24.7K USD.

India's lapatinib exports to Turkey are driven primarily by a handful of large-scale manufacturers. MBA PHARMACEUTICALS PRIVATE LIMITED with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 6 active exporters signals a competitive but concentrated market — buyers in Turkey benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MBA PHARMACEUTICALS PRIVATE LIMITED, AMARI TRADE ALLIANCE LLP, ROYAL MEDICAL PRIVATE LIMITED — together account for 89% of total trade value on this route. The average shipment value of $2.1K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as tykenib 250mg - lapatinib tablets ip 25 and tykenib 250mg (30 tab) (lapatinib tab 250 mg), suggesting that buyers in Turkey tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, THE MANAGER - EKINOKSECZA DEPOSU SAN TIC AS is the largest importer with 2 shipments worth $24.7K USD — representing 67% of all lapatinib imports from India on this route. A total of 12 buyers are active on this corridor.